Skip to main content
Homepage
Full 18-step deep-dive · ~20–30 min · a member feature.
No report run on this ticker yet Only preliminary foundational data below
For AI assistants & researchers — machine-readable summary of this page

What this page is: Delvantic's full research page for CNO Financial Group Inc. (CNO) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.

Page map (sections in order; each card carries a stable reference-name attribute you can cite):

  • profile-header / price-overview — company profile, live quote, market cap
  • extended-analysisthe core: three AI lens reads with findings, scores, and the analyst memo
  • future-predictions — our forward price-band predictions
  • market-narrative / ai-findings / gpt-critique — narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)
  • Members-only sections (render as login gates for anonymous readers): price-history, income-trend, key-metrics, financials (statement tables), insider-trading. The analysis above is public; the raw data tables require a free account.

More for machine readers: site briefing at /llms.txt · any ticker resolves at delvantic.com/stock/TICKER · raw inputs are public-company filings and market data (via licensed data feeds); every model, score, lens read, and prediction on this page is Delvantic's own analysis.

CNO Financial Group Inc.

CNO NYSE
Financial Services · Insurance - Life
Carmel, IN 46032, United States cnoinc.com Updated Aug 14, 8:36am
Price
$54.85
Market Cap
$5.1B
Employees
3,300
Beta
0.82
Avg Volume
667,561
Last Dividend
$0.69
CEO
Mr. Gary Chandru Bhojwani

CNO Financial Group Inc. is a holding company for a portfolio of insurance-oriented subsidiaries. Predominantly serving middle-income Americans, CNO Financial provides insurance products such as life insurance, annuities, and supplemental health insurance. The company's offerings are tailored to meet the diverse financial needs of customers who are either in or approaching retirement. CNO Financial Group distributes its products through career agents, independent producers, and direct marketing channels, ensuring broad reach and accessibility. Operating primarily within the United States, the company holds a significant position within the insurance industry, facilitating financial protection and security for its users. CNO's role in the financial market is crucial as it helps mitigate financial risks for individuals, contributing to the overall stability and growth of the economy by supporting the retirement and healthcare needs of its clients. Established in 1979, CNO Financial Group is headquartered in Carmel, Indiana, and emphasizes a commitment to customer service and community involvement as cornerstones of its enduring reputation.

Runs with full report
Earnings Schedule
Checked daily · calendar updated Aug 14
No upcoming print on the calendar yet — companies typically confirm a few weeks ahead. Last print was Jul 30, 2026.
EPS surprise history — vs analyst consensus · 3 prints of vendor history
+74.3%
Mar '26
-58.1%
Apr '26
+29.9%
Jul '26
Print date EPS est. EPS actual Revenue est. Revenue actual
Jul 30, 2026 $0.97 $1.26 +29.9%
Apr 30, 2026 $0.93 $0.39 -58.1%
Mar 27, 2026 $-3.78 $-0.97 +74.3%

Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.

Recent SEC Filings
Filed Form Document
Aug 12, 2026 13F-HR View
Aug 6, 2026 10-Q View
Jul 30, 2026 8-K View
Jul 1, 2026 144 View
Jul 1, 2026 4 View
Jul 1, 2026 4 View
Jun 30, 2026 144 View
Jun 11, 2026 144 View
Jun 11, 2026 4 View
Jun 10, 2026 144 View
Jun 8, 2026 4 View
Jun 4, 2026 4 View

Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.

Price Overview
Last updated: Aug 14, 2026 8:36am (just now)
Current data · timestamped when a report runs
$54.85
Change · Aug 14
+0.57 (+1.05%)
Day Range
$54.37 – $55.00
52-Week Range
$37.36 – $57.59
50-Day MA
$52.32
200-Day MA
$44.93
Volume
344,763.00
Share Structure
Outstanding 92,697,000.00
Float 88,579,961.00
Free Float 95.6%
High free float — 95.6% of shares trade freely, ~4.4% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Aug 14, 2026 8:36am (just now)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Aug 14, 2026 8:36am (just now)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
TD Twelve Data statement HEX SEC filing
P/E Ratio (Price per dollar of earnings)
HEX
Stock Price / EPS (Diluted)
23.85
Stock Price: $54.85
EPS (Diluted): 2.30
P/B Ratio (Price vs net asset value)
HEX
Stock Price / Book Value Per Share
2.07
Stock Price: $54.85
Total Equity: $2.64B
Shares: 99,695,652
EV/EBITDA (Total value vs operating profit)
HEX
Enterprise Value / EBITDA
Market Cap: $5.07B
Total Debt: $0.00
Cash: $983.50M
EBITDA: N/A
EBITDA not available
Enterprise Value (Takeover price (cap + debt - cash))
HEX
Market Cap + Total Debt - Cash
$5.1B
Market Cap: $5.07B
Total Debt: $0.00
Cash: $983.50M
Gross Margin (Revenue left after direct costs)
HEX
Gross Profit / Revenue
Gross Profit: N/A
Revenue: $4.49B
Missing from API: Gross Profit
Operating Margin (Revenue left after all operations)
HEX
Operating Income / Revenue
Operating Income: N/A
Revenue: $4.49B
Missing from API: Operating Income
Net Margin (Revenue left as actual profit)
HEX
Net Income / Revenue
5.1%
Net Income: $229.30M
Revenue: $4.49B
ROE (Profit from shareholder equity)
HEX
Net Income / Total Equity
8.7%
Net Income: $229.30M
Total Equity: $2.64B
ROIC (Profit from all invested capital)
HEX
NOPAT / Invested Capital
Operating Income: N/A
Tax Rate: 21.8%
Equity: $2.64B
Total Debt: $0.00
Cash: $983.50M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
HEX
Current Assets / Current Liabilities
Current Assets: N/A
Current Liabilities: N/A
Missing from API: Current Assets, Current Liabilities
Debt/Equity (Leverage — debt vs equity)
HEX
Total Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $2.64B
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
HEX
Revenue / Shares Outstanding
$45.01
Revenue: $4.49B
Shares: 99,695,652
Book Value/Share (Net assets per share)
HEX
(Total Assets - Total Liabilities) / Shares
$26.46
Total Equity: $2.64B
Shares: 99,695,652
FCF/Share (Real cash generated per share)
HEX
(Operating Cash Flow + CapEx) / Shares
$6.78
Operating CF: $675.70M
CapEx: $0.00
Shares: 99,695,652
Div Yield (Annual income from holding)
TD
Last Annual Dividend / Stock Price
1.3%
Last Dividend: $0.69
Stock Price: $54.85
Payout Ratio (Earnings paid out as dividends)
HEX
Dividends Paid / Net Income
28.9%
Dividends Paid: -$66.20M
Net Income: $229.30M
Income Statement (Annual)
Last updated: Aug 14, 2026 8:36am (just now)
Metric 2021 2022 2023 2024 2025
Revenue $4.1B $3.6B $4.1B $4.4B $4.5B
Cost of Revenue
Gross Profit
Operating Expenses $870.9M $836.7M $937.2M $933.5M $985.0M
Operating Income
Net Income $570.3M $630.6M $276.5M $404.0M $229.3M
EBITDA
EPS $3.43 $3.43 $2.44 $3.81 $2.35
EPS (Diluted) $3.36 $3.37 $2.40 $3.74 $2.30
Balance Sheet (Annual)
Last updated: Aug 14, 2026 8:36am (just now)
Metric 2022 2023 2024 2025 2025
Cash & Equivalents $644.9M $889.0M $2.0B $983.5M
Total Current Assets
Total Assets $33.3B $35.1B $37.9B $38.8B
Current Liabilities
Long-Term Debt
Total Liabilities $31.9B $32.9B $35.4B $36.2B
Total Equity $1.4B $2.2B $2.5B $2.6B
Retained Earnings $1.5B $1.9B $2.2B $2.4B
Cash Flow (Annual)
Last updated: Aug 14, 2026 8:36am (just now)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $598.3M $495.4M $582.9M $627.7M $675.7M
Capital Expenditure
Free Cash Flow
Acquisitions (net)
Net Debt Issued / (Repaid) $0 $0 $0 $691.0M $0
Dividends Paid -$65.7M -$64.8M -$68.1M -$67.7M -$66.2M
Stock Buybacks -$407.8M -$190.1M -$166.1M -$300.2M -$331.4M
Net Change in Cash -$260.2M -$86.8M $244.1M $1.1B -$1.0B
Growth Trends (YoY %)
Last updated: Aug 14, 2026 8:36am (just now)
Metric 2022 2023 2024 2025
Revenue Growth -13.2% +15.9% +7.2% +0.9%
Gross Profit Growth
Operating Income Growth
Net Income Growth +10.6% -56.2% +46.1% -43.2%
EBITDA Growth
Dividend History (Last 20)
Last updated: Aug 14, 2026 8:36am (just now)
Date Dividend Declaration Record Payment
2026-06-10 $0.18
2026-03-10 $0.17
2025-12-10 $0.17
2025-09-10 $0.17
2025-06-10 $0.17
2025-03-10 $0.16
2024-12-10 $0.16
2024-09-10 $0.16
2024-06-10 $0.16
2024-03-07 $0.15
2023-12-07 $0.15
2023-09-07 $0.15
2023-06-08 $0.15
2023-03-09 $0.14
2022-12-08 $0.14
2022-09-08 $0.14
2022-06-09 $0.14
2022-03-09 $0.13
2021-12-09 $0.13
2021-09-09 $0.13
Industry Benchmarks
Compares CNO against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for CNO — it's generated by the pipeline (market-narrative step).
Claude Reading
Claude Opus reviews the pipeline's raw data + every prior verdict, then writes an independent take.
No AI findings yet for CNO — they're generated by the pipeline (ai-findings step) when a report is run on this ticker.
GPT Reading
GPT reads the identical raw briefing blind — one of the Big-3 independent readings — and commits to its own verdict.
No GPT reading yet for CNO — it's generated by the pipeline (gpt-critique step) after the other Big-3 seats, when a report is run on this ticker.
Grok Reading
Grok (xAI) reads the identical raw briefing blind — one of the Big-3 independent readings — and commits to its own verdict.
No Grok reading yet for CNO — it's generated by the pipeline (grok-critique step) alongside the other Big-3 seats, when a report is run on this ticker.
Advanced Analysis Forensic deep-dive · four lenses
A separate, manually-run forensic pipeline (dilution, earnings quality, liquidity → two scored lenses → the play). Hasn't been run for this ticker yet.
Community AI Feedback
No community reviews yet for CNO. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · twelvedata
v1.1.532 · 1ec19de8 · 2026-08-13 17:53:37